Asian Spectator


The Times

.

LANDMARK’s ‘Destination CENTRAL’ Opens an Inspiring New Chapter for the Festive Season in Hong Kong

Heightening the Global Momentum of Louis Vuitton’s Monumental Façade and Welcoming the Arrival of “Christmas at The Gloucester Hotel”HONG KONG SAR – Media OutReach News...

Southco Asia Expands Manufacturing Operations in Gaoming, Foshan to Meet Growing Demand

HONG KONG SAR - Media OutReach Newswire - 25 June 2024 - Southco Asia Ltd., a subsidiary of Southco Inc., a leading global provider of engineered access solutions such as locks, latches, ca...

Supermicro JumpStart Early Access Program Accelerates Time to ...

SAN JOSE, Calif., Oct. 6, 2022 /PRNewswire-Asianet/ -- --JumpStart Program Will Provide Pre-Release Online NDA Access for X13 EarlyPerformance Testing and Validation of 4th Gen Intel Xeon S...

Over 50% of people would turn to VPNs if social media platforms like Instagram were banned in Hong Kong

HONG KONG SAR - Media OutReach - 11 May 2022 - Digital Business Lab and Standard Insights conducted a survey campaign in Hong Kong to understand the active population's perception, prefere...

Angela Hornby joins Sedgwick as head of capability advancement...

SYDNEY, Feb. 15, 2022 /PRNewswire-AsiaNet/ -- Sedgwick [ https://c212.net/c/link/?t=0&l=en&o=3442993-1&h=1303601274&u=https%3A%2F%2Fwww.sedgwick.com%2F&a=Sedgwick ], a le...

AstraZeneca tops the first Pharmaceutical Invention Index

LONDON, Nov. 3,2019, /PRNewswire-AsiaNet/ - The first annual ranking of pipeline novelty in global pharma by IDEA Pharma The first annual Pharmaceutical Invention Index, released by IDEA Pha...

Mobileum Inc. Acquires Developing Solutions

CUPERTINO, Calif., June 22, 2021, /PRNewswire-AsiaNet/-- Acquisition Expands Mobileum's Market Leadership in 5G TestingMobileum Inc. ("Mobileum"), a leading global provider of analytics solu...

Orocobre Limited - Olaroz Stage 2 Expansion FID Approved

BRISBANE, Australia, Nov. 28, 2018 /PRNewswire-AsiaNet/ -- Orocobre Limited (ASX: ORE, TSX: ORL) ("Orocobre" or "the Company") is pleased to advise that Orocobre, Toyota Tsusho Corporation (...

FT PWM Report Ranks Dominica Best Citizenship by Investment Pr...

ROSEAU, Dominica, Aug. 18, 2021 /PRNewswire-AsiaNet/ -- The Commonwealth of Dominica has topped the chart with the best citizenship by investment (CBI) programme [ http://www.cbiu.gov.dm/ ]i...

Eisai: New Fine Granule Formulation of Anti-epileptic Drug Fycompa Launched in Japan

Eisai: New Fine Granule Formulation of Anti-epileptic Drug Fycompa Launched in Japan

TOKYO, Jul 6, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has launched a new fine granule formulation of its in-house-discovered antiepileptic drug (AED) Fycompa (perampanel hydrate) in Japan on July 6, 2020. Eisai received marketing and manufacturing approval for this formulation on January 23, 2020, and the fine granule formulation was added to Japan's National Health Insurance drug price list on April 23 of the same year.

In Japan, it is estimated that there are approximately 1 million patients with epilepsy. While epilepsy is a disease that may occur regardless of age, it is said that incidence is particularly high in children and the elderly. This newly launched fine granule formula was developed so that even patients who have difficulty taking tablets such as children or those who have difficulties in taking tablets due to reduced swallowing ability may take this drug. Additionally, greater ability to adjust dosage to match patients' symptoms becomes possible.

Fycompa is a first-in-class AED discovered at Eisai's Tsukuba Research Laboratories and was developed in-house. It is a highly selective, noncompetitive AMPA receptor antagonist that reduces neuronal hyperexcitation associated with seizures by targeting glutamate activity at postsynaptic AMPA receptors. In Japan, Fycompa is currently approved for monotherapy and adjunctive use in the treatment of partial-onset seizures (with or without secondarily generalized seizures) in patients with epilepsy 4 years of age and older, as well as adjunctive treatment for primary generalized tonic-clonic seizures in patients with epilepsy 12 years of age and older.With the launch of this fine granule formulation in Japan, Eisai will continue to prioritize the provision of safety information. Furthermore, Eisai will pursue its mission of delivering "seizure freedom" to as many patients as possible, and seek to address the diverse needs of, as well as increasing the benefits provided to, patients with epilepsy and their families.

About Eisai

Eisai Co., Ltd. defines our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products to address unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology. As a global pharmaceutical company, our mission extends to patients around the world through working with key stakeholders to improve access to medicines in developing and emerging countries.

For more information about Eisai Co., Ltd., please visit https://www.eisai.com

Contact:Public Relations Department
Eisai Co., Ltd. 
+81-(0)3-3817-5120

Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink esim senegalzlibraryzlibraryuk casinos not on gamstophttps://www.capitolcitycinema.org/grandpashabet girişStreamEastCrackStreamscialis 20 mg fiyathttps://elektroniksigarakeyfi.net/marka/voopoo/taraftarium24taraftarium24taraftarium24